These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. No association between histamine N-methyltransferase functional polymorphism Thr105Ile and Alzheimer's disease. Marasović-Šušnjara I; Palada V; Marinović-Terzić I; Mimica N; Marin J; Muck-Seler D; Mustapić M; Presečki P; Pivac N; Folnegović-Šmalc V; Marinović-Ćurin J; Terzić J Neurosci Lett; 2011 Feb; 489(2):119-21. PubMed ID: 21138759 [TBL] [Abstract][Full Text] [Related]
3. Contribution of astrocytic histamine N-methyltransferase to histamine clearance and brain function in mice. Otsuka R; Naganuma F; Nakamura T; Miwa H; Nakayama-Naono R; Matsuzawa T; Komatsu Y; Sato Y; Takahashi Y; Tatsuoka-Kitano H; Yanai K; Yoshikawa T Neuropharmacology; 2022 Jul; 212():109065. PubMed ID: 35487272 [TBL] [Abstract][Full Text] [Related]
4. Neuronal histamine and cognitive symptoms in Alzheimer's disease. Zlomuzica A; Dere D; Binder S; De Souza Silva MA; Huston JP; Dere E Neuropharmacology; 2016 Jul; 106():135-45. PubMed ID: 26025658 [TBL] [Abstract][Full Text] [Related]
5. Multifunctional Compound AD-35 Improves Cognitive Impairment and Attenuates the Production of TNF-α and IL-1β in an Aβ25-35-induced Rat Model of Alzheimer's Disease. Li L; Xu S; Liu L; Feng R; Gong Y; Zhao X; Li J; Cai J; Feng N; Wang L; Wang X; Peng Y J Alzheimers Dis; 2017; 56(4):1403-1417. PubMed ID: 28157092 [TBL] [Abstract][Full Text] [Related]
6. [Analysis of brain histamine clearance using genetically engineered mice]. Yoshikawa T; Nakamura T; Yanai K Nihon Yakurigaku Zasshi; 2018; 152(1):16-20. PubMed ID: 29998947 [TBL] [Abstract][Full Text] [Related]
9. Neuronal histaminergic system in aging and age-related neurodegenerative disorders. Shan L; Swaab DF; Bao AM Exp Gerontol; 2013 Jul; 48(7):603-7. PubMed ID: 22910064 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of rat brain histamine-N-methyltransferase by 9-amino-1,2,3,4-tetrahydroacridine (THA). Cumming P; Reiner PB; Vincent SR Biochem Pharmacol; 1990 Sep; 40(6):1345-50. PubMed ID: 2403387 [TBL] [Abstract][Full Text] [Related]
11. Human brain cytosolic histamine-N-methyltransferase is decreased in Down syndrome and increased in Pick's disease. Kim SH; Krapfenbauer K; Cheon MS; Fountoulakis M; Cairns NJ; Lubec G Neurosci Lett; 2002 Mar; 321(3):169-72. PubMed ID: 11880199 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of histamine-N-methyltransferase (HNMT) by fragments of 9-amino-1,2,3,4-tetrahydroacridine (tacrine) and by beta-carbolines. Cumming P; Vincent SR Biochem Pharmacol; 1992 Sep; 44(5):989-92. PubMed ID: 1530666 [TBL] [Abstract][Full Text] [Related]
13. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
14. Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer's Disease. Le Douce J; Maugard M; Veran J; Matos M; Jégo P; Vigneron PA; Faivre E; Toussay X; Vandenberghe M; Balbastre Y; Piquet J; Guiot E; Tran NT; Taverna M; Marinesco S; Koyanagi A; Furuya S; Gaudin-Guérif M; Goutal S; Ghettas A; Pruvost A; Bemelmans AP; Gaillard MC; Cambon K; Stimmer L; Sazdovitch V; Duyckaerts C; Knott G; Hérard AS; Delzescaux T; Hantraye P; Brouillet E; Cauli B; Oliet SHR; Panatier A; Bonvento G Cell Metab; 2020 Mar; 31(3):503-517.e8. PubMed ID: 32130882 [TBL] [Abstract][Full Text] [Related]
15. Molecular mechanism of histamine clearance by primary human astrocytes. Yoshikawa T; Naganuma F; Iida T; Nakamura T; Harada R; Mohsen AS; Kasajima A; Sasano H; Yanai K Glia; 2013 Jun; 61(6):905-16. PubMed ID: 23505051 [TBL] [Abstract][Full Text] [Related]
16. Thioperamide attenuates neuroinflammation and cognitive impairments in Alzheimer's disease via inhibiting gliosis. Wang J; Liu B; Xu Y; Luan H; Wang C; Yang M; Zhao R; Song M; Liu J; Sun L; You J; Wang W; Sun F; Yan H Exp Neurol; 2022 Jan; 347():113870. PubMed ID: 34563511 [TBL] [Abstract][Full Text] [Related]
17. Drug Repurposing to Inhibit Histamine Jiménez EM; Żołek T; Hernández Perez PG; Miranda Ruvalcaba R; Nicolás-Vázquez MI; Hernández-Rodríguez M Molecules; 2023 Jan; 28(2):. PubMed ID: 36677633 [TBL] [Abstract][Full Text] [Related]
18. Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer's disease model mice. Xie X; Gao Y; Zeng M; Wang Y; Wei TF; Lu YB; Zhang WP Metab Brain Dis; 2019 Feb; 34(1):353-366. PubMed ID: 30523581 [TBL] [Abstract][Full Text] [Related]
19. Similar deficits of central histaminergic system in patients with Down syndrome and Alzheimer disease. Schneider C; Risser D; Kirchner L; Kitzmüller E; Cairns N; Prast H; Singewald N; Lubec G Neurosci Lett; 1997 Feb; 222(3):183-6. PubMed ID: 9148245 [TBL] [Abstract][Full Text] [Related]
20. Histamine N-methyltransferase functional polymorphism: lack of association with schizophrenia. Yan L; Szumlanski CL; Rice SR; Sobell JL; Lachman HM; Weinshilboum RM Am J Med Genet; 2000 Jun; 96(3):404-6. PubMed ID: 10898922 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]